Literature DB >> 3123872

Failure of haemoperfusion to reduce flecainide intoxication. A case study.

J Braun1, J R Kollert, U Gessler, J U Becker.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3123872     DOI: 10.1007/bf03259879

Source DB:  PubMed          Journal:  Med Toxicol Adverse Drug Exp        ISSN: 0113-5244


× No keyword cloud information.
  12 in total

1.  [Hemoperfusion in flecainide poisoning].

Authors:  R Wurzberger; E Witter; H Avenhaus; H Hennemann; J U Becker
Journal:  Klin Wochenschr       Date:  1986-05-02

Review 2.  A classification of antiarrhythmic actions reassessed after a decade of new drugs.

Authors:  E M Vaughan Williams
Journal:  J Clin Pharmacol       Date:  1984-04       Impact factor: 3.126

3.  The influence of urinary pH on flecainide excretion and its serum pharmacokinetics.

Authors:  K A Muhiddin; A Johnston; P Turner
Journal:  Br J Clin Pharmacol       Date:  1984-04       Impact factor: 4.335

4.  Suppression of resistant ventricular arrhythmias by twice daily dosing with flecainide.

Authors:  H J Duff; D M Roden; R J Maffucci; B S Vesper; G J Conard; S B Higgins; J A Oates; R F Smith; R L Woosley
Journal:  Am J Cardiol       Date:  1981-12       Impact factor: 2.778

5.  Pharmacokinetics of flecainide in patients with mild and moderate renal failure compared with patients with normal renal function.

Authors:  J Braun; J R Kollert; J U Becker
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

6.  A comparison of the antiarrhythmic effects on AV junctional re-entrant tachycardia of oral and intravenous flecainide acetate.

Authors:  R S Bexton; K J Hellestrand; A W Nathan; R A Spurrell; A J Camm
Journal:  Eur Heart J       Date:  1983-02       Impact factor: 29.983

Review 7.  Metabolism of flecainide.

Authors:  G J Conard; R E Ober
Journal:  Am J Cardiol       Date:  1984-02-27       Impact factor: 2.778

8.  Suppression of ventricular ectopic depolarizations by flecainide acetate, a new antiarrhythmic agent.

Authors:  M Hodges; J M Haugland; G Granrud; G J Conard; R W Asinger; F L Mikell; J Krejci
Journal:  Circulation       Date:  1982-05       Impact factor: 29.690

9.  [Determination of the concentration of a new antiarrhythmic, flecainide, in plasma using high pressure liquid chromatography (HPLC): sample preparation with extraction columns].

Authors:  J U Becker
Journal:  J Clin Chem Clin Biochem       Date:  1984-05

10.  Flecainide pharmacokinetics in healthy volunteers: the influence of urinary pH.

Authors:  A Johnston; S Warrington; P Turner
Journal:  Br J Clin Pharmacol       Date:  1985-10       Impact factor: 4.335

View more
  2 in total

1.  Altered flecainide disposition in healthy volunteers taking quinine.

Authors:  A Munafo; G Reymond-Michel; J Biollaz
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

2.  Primary and secondary detoxification in severe flecainide intoxication.

Authors:  D Götz; S Pohle; D Barckow
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.